Open Access
Advances in Experimental Medicine and Biology
SCImago
Q3
SJR
0.244
CiteScore
5.9
Categories
Biochemistry, Genetics and Molecular Biology (miscellaneous)
Medicine (miscellaneous)
Areas
Biochemistry, Genetics and Molecular Biology
Medicine
Years of issue
1971-2025
journal names
Advances in Experimental Medicine and Biology
Top-3 citing journals
![Advances in Experimental Medicine and Biology](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
Advances in Experimental Medicine and Biology
(8358 citations)
![International Journal of Molecular Sciences](/storage/images/resized/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_large.webp)
International Journal of Molecular Sciences
(8058 citations)
![PLoS ONE](/storage/images/resized/PRGhlgB4OKRltSNtT39eA6wlnOTGRap1QQ6FQHih_large.webp)
PLoS ONE
(4460 citations)
Top-3 organizations
![Harvard University](/storage/images/resized/O7CzqtizxzuufyNEXdD14Pazh1iICAmqjNAiQRKA_large.webp)
Harvard University
(582 publications)
![University of Pennsylvania](/storage/images/resized/PgsxFioq3mI2Y5m4HCJphXiD0wqO7w066pXHQ5YI_large.webp)
University of Pennsylvania
(522 publications)
![Johns Hopkins University](/storage/images/resized/y9D9RA5NB6uefKoOeeC9vy1hD4wj24pWD9YoGcur_large.webp)
Johns Hopkins University
(363 publications)
![Mashhad University of Medical Sciences](/storage/images/resized/wkX2RqnTFnz8Kk0SwiH5OPAFhspd3mNRo1JYTqof_large.webp)
Mashhad University of Medical Sciences
(137 publications)
![Ionian University](/storage/images/resized/F4H9pKgUA3NzgPfw5F1uxEIHgKbFscRK59ztOTtx_large.webp)
Ionian University
(108 publications)
![Tehran University of Medical Sciences](/storage/images/resized/vndYFo7Inc0KkmSRhEGJ3r9UQxBjabWSqGUEIMBY_large.webp)
Tehran University of Medical Sciences
(95 publications)
Top-3 countries
Most cited in 5 years
Nothing found, try to update filter.
Chan H., Samala R.K., Hadjiiski L.M., Zhou C.
Deep learning is the state-of-the-art machine learning approach. The success of deep learning in many pattern recognition applications has brought excitement and high expectations that deep learning, or artificial intelligence (AI), can bring revolutionary changes in health care. Early studies of deep learning applied to lesion detection or classification have reported superior performance compared to those by conventional techniques or even better than radiologists in some tasks. The potential of applying deep-learning-based medical image analysis to computer-aided diagnosis (CAD), thus providing decision support to clinicians and improving the accuracy and efficiency of various diagnostic and treatment processes, has spurred new research and development efforts in CAD. Despite the optimism in this new era of machine learning, the development and implementation of CAD or AI tools in clinical practice face many challenges. In this chapter, we will discuss some of these issues and efforts needed to develop robust deep-learning-based CAD tools and integrate these tools into the clinical workflow, thereby advancing towards the goal of providing reliable intelligent aids for patient care.
Zhang L., Lu Q., Chang C.
Epigenetic mechanisms, which include DNA methylation, histone modification, and microRNA (miRNA), can produce heritable phenotypic changes without a change in DNA sequence. Disruption of gene expression patterns which are governed by epigenetics can result in autoimmune diseases, cancers, and various other maladies. Mechanisms of epigenetics include DNA methylation (and demethylation), histone modifications, and non-coding RNAs such as microRNAs. Compared to numerous studies that have focused on the field of genetics, research on epigenetics is fairly recent. In contrast to genetic changes, which are difficult to reverse, epigenetic aberrations can be pharmaceutically reversible. The emerging tools of epigenetics can be used as preventive, diagnostic, and therapeutic markers. With the development of drugs that target the specific epigenetic mechanisms involved in the regulation of gene expression, development and utilization of epigenetic tools are an appropriate and effective approach that can be clinically applied to the treatment of various diseases.
Ai L., Xu A., Xu J.
Immunotherapies that target PD-1/PD-L1 axis have shown unprecedented success in a wide variety of human cancers. PD-1 is one of the key coinhibitory receptors expressed on T cells upon T cell activation. After engagement with its ligands, mainly PD-L1, PD-1 is activated and recruits the phosphatase SHP-2 in proximity to T cell receptor (TCR) and CD28 signaling. This event results in dephosphorylation and attenuation of key molecules in TCR and CD28 pathway, leading to inhibition of T cell proliferation, activation, cytokine production, altered metabolism and cytotoxic T lymphocytes (CTLs) killer functions, and eventual death of activated T cells. Bodies evolve coinhibitory pathways controlling T cell response magnitude and duration to limit tissue damage and maintain self-tolerance. However, tumor cells hijack these inhibitory pathways to escape host immune surveillance by overexpression of PD-L1. This provides the scientific rationale for clinical application of immune checkpoint inhibitors in oncology. The aberrantly high expression of PD-L1 in tumor microenvironment (TME) can be attributable to the “primary” activation of multiple oncogenic signaling and the “secondary” induction by inflammatory factors such as IFN-γ. Clinically, antibodies targeting PD-1/PD-L1 reinvigorate the “exhausted” T cells in TME and show remarkable objective response and durable remission with acceptable toxicity profile in large numbers of tumors such as melanoma, lymphoma, and mismatch-repair deficient tumors. Nevertheless, most patients are still refractory to anti-PD-1/PD-L1 therapy. Identifying the predictive biomarkers and design rational PD-1-based combination therapy become the priorities in cancer immunotherapy. PD-L1 expression, cytotoxic T lymphocytes infiltration, and tumor mutation burden (TMB) are generally considered as the most important factors affecting the effectiveness of PD-1/PD-L1 blockade. The revolution in cancer immunotherapy achieved by PD-1/PD-L1 blockade offers the paradigm for scientific translation from bench to bedside. The next decades will without doubt witness the renaissance of immunotherapy.
Zhang Y., Sun Z., Jia J., Du T., Zhang N., Tang Y., Fang Y., Fang D.
Epigenetics is the epi-information beyond the DNA sequence that can be inherited from parents to offspring. From years of studies, people have found that histone modifications, DNA methylation, and RNA-based mechanism are the main means of epigenetic control. In this chapter, we will focus on the general introductions of epigenetics, which is important in the regulation of chromatin structure and gene expression. With the development and expansion of high-throughput sequencing, various mutations of epigenetic regulators have been identified and proven to be the drivers of tumorigenesis. Epigenetic alterations are used to diagnose individual patients more accurately and specifically. Several drugs, which are targeting epigenetic changes, have been developed to treat patients regarding the awareness of precision medicine. Emerging researches are connecting the epigenetics and cancers together in the molecular mechanism exploration and the development of druggable targets.
Leiter U., Keim U., Garbe C.
Melanoma and keratinocyte skin cancer (KSC) are the most common types of cancer in White-skinned populations. Both tumor entities showed increasing incidence rates worldwide but stable or decreasing mortality rates. Rising incidence rates of cutaneous melanoma (CM) and KSC are largely attributed to increasing exposure to ultraviolet (UV) radiation, the main causal risk factor for skin cancer. Incidence rates of KSC, comprising of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), are much higher than that of melanoma. BCC development is mainly the cause of an intensive UV exposure in childhood and adolescence, while SCC development is related to chronic, cumulative UV exposure over decades. Although mortality is relatively low, KSC is an increasing problem for health care services causing significant morbidity. Cutaneous melanoma is rapidly increasing in White populations, with an estimated annual increase of around 3–7% over the past decades. In contrast to SCC, melanoma risk is associated with intermittent and chronic exposure to sunlight. The frequency of its occurrence is closely associated with the constitutive color of the skin and the geographical zone. Changes in outdoor activities and exposure to sunlight during the past 70 years are an important factor for the increasing incidence of melanoma. Mortality rates of melanoma show stabilization in the USA, Australia, and in European countries. In the USA even dropping numbers of death cases were recently reported, probably reflecting efficacy of the new systemic treatments. Among younger cohorts in some populations (e.g., Australia and New Zealand,), stabilizing or declining incidence rates of CM are observed, potentially caused by primary prevention campaigns aimed at reducing UV exposure. In contrast, incidence rates of CM are still rising in most European countries and in the USA. Ongoing trends towards thinner melanoma are largely ascribed to earlier detection.
Zhang Y., Zheng J.
Immune checkpoint molecules, including inhibitory and stimulatory immune checkpoint molecules, are defined as ligand–receptor pairs that exert inhibitory or stimulatory effects on immune responses. Most of the immune checkpoint molecules that have been described so far are expressed on cells of the adaptive immune system, particularly on T cells, and of the innate immune system. They are crucial for maintaining the self-tolerance and modulating the length and magnitude of immune responses of effectors in different tissues to minimize the tissue damage. More and more evidences have shown that inhibitory or stimulatory immune checkpoint molecules are expressed on a sizeable fraction of tumor types. Although the main function of tumor cell-associated immune checkpoint molecules is considered to mediate the immune evasion, it has been reported that the immune checkpoint molecules expressed on tumor cells also play important roles in the maintenance of many malignant behaviors, including self-renewal, epithelial–mesenchymal transition, metastasis, drug resistance, anti-apoptosis, angiogenesis, or enhanced energy metabolisms. In this section, we mainly focus on delineating the roles of the tumor cell-associated immune checkpoint molecules beyond immune evasion, such as PD-L1, PD-1, B7-H3, B7-H4, LILRB1, LILRB2, TIM3, CD47, CD137, and CD70.
Dysthe M., Parihar R.
Myeloid-derived suppressor cells (MDSCs) represent a heterogenous population of immature myeloid cells capable of modulating immune responses. In the context of cancer, MDSCs are abnormally produced and recruited to the tumor microenvironment (TME) to aid in the establishment of an immunosuppressive TME that facilitates tumor escape. Additionally, MDSCs contribute to non-immunologic aspects of tumor biology, including tumor angiogenesis and metastasis. The clinical significance of MDSCs has recently been appreciated as numerous studies have suggested a correlation between circulating and intratumoral MDSC frequencies and tumor stage, progression, and treatment resistance. In this chapter, we review MDSC characterization, development, expansion, and mechanisms that facilitate immunosuppression and tumor progression. Furthermore, we highlight studies demonstrating the clinical significance of MDSCs in various disease states in addition to strategies that modulate various aspects of MDSC biology for therapeutic gain.
Shao C., Wang J., Tian J., Tang Y.
In most developed countries, coronary artery disease (CAD), mostly caused by atherosclerosis of coronary arteries, is one of the primary causes of death. From 1990s to 2000s, mortality caused by acute MI declined up to 50%. The incidence of CAD is related with age, gender, economic, etc. Atherosclerosis contains some highly correlative processes such as lipid disturbances, thrombosis, inflammation, vascular smooth cell activation, remodeling, platelet activation, endothelial dysfunction, oxidative stress, altered matrix metabolism, and genetic factors. Risk factors of CAD exist among many individuals of the general population, which includes hypertension, lipids and lipoproteins metabolism disturbances, diabetes mellitus, chronic kidney disease, age, genders, lifestyle, cigarette smoking, diet, obesity, and family history. Angina pectoris is caused by myocardial ischemia in the main expression of pain in the chest or adjoining area, which is usually a result of exertion and related to myocardial function disorder. Typical angina pectoris would last for minutes with gradual exacerbation. Rest, sit, or stop walking are the usual preference for patients with angina, and reaching the maximum intensity in seconds is uncommon. Rest or nitroglycerin usage can relieve typical angina pectoris within minutes. So far, a widely accepted angina pectoris severity grading system included CCS (Canadian Cardiovascular Society) classification, Califf score, and Goldman scale. Patients with ST-segment elevated myocardial infarction (STEMI) may have different symptoms and signs of both severe angina pectoris and various complications. The combination of rising usage of sensitive MI biomarkers and precise imaging techniques, including electrocardiograph (ECG), computed tomography, and cardiac magnetic resonance imaging, made the new MI criteria necessary. Complications of acute myocardial infarction include left ventricular dysfunction, cardiogenic shock, structural complications, arrhythmia, recurrent chest discomfort, recurrent ischemia and infarction, pericardial effusion, pericarditis, post-myocardial infarction syndrome, venous thrombosis pulmonary embolism, left ventricular aneurysm, left ventricular thrombus, and arterial embolism.
Santana-Codina N., Gikandi A., Mancias J.D.
Nuclear receptor coactivator 4 (NCOA4) is a selective cargo receptor that mediates the autophagic degradation of ferritin, the cytosolic iron storage complex, in a process known as ferritinophagy. NCOA4-mediated ferritinophagy is required to maintain intracellular and systemic iron homeostasis and thereby iron-dependent physiologic processes such as erythropoiesis. Given this role of ferritinophagy in regulating iron homeostasis, modulating NCOA4-mediated ferritinophagic flux alters sensitivity to ferroptosis, a non-apoptotic iron-dependent form of cell death triggered by peroxidation of polyunsaturated fatty acids (PUFAs). A role for ferroptosis has been established in the pathophysiology of cancer and neurodegeneration; however, the importance of ferritinophagy in these pathologies remains largely unknown. Here, we review the available evidence on biochemical regulation of NCOA4-mediated ferritinophagy and its role in modulating sensitivity to innate and induced ferroptosis in neurodegenerative diseases and cancer. Finally, we evaluate the potential of modulating ferritinophagy in combination with ferroptosis inducers as a therapeutic strategy.
Van Coillie S., Wiernicki B., Xu J.
Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) is an inhibitory receptor belonging to the CD28 immunoglobulin subfamily, expressed primarily by T-cells. Its ligands, CD80 and CD86, are typically found on the surface of antigen-presenting cells and can either bind CD28 or CTLA-4, resulting in a costimulatory or a co-inhibitory response, respectively. Because of its dampening effect, CTLA-4 is a crucial regulator of T-cell homeostasis and self-tolerance. The mechanisms by which CTLA-4 exerts its inhibitory function can be categorized as either cell-intrinsic (affects the CTLA-4 expressing T-cell) or cell-extrinsic (affects secondary cells). Research from the last decade has shown that CTLA-4 mainly acts in a cell-extrinsic manner via its competition with CD28, CTLA-4-mediated trans-endocytosis of CD80 and CD86, and its direct tolerogenic effects on the interacting cell. Nonetheless, intrinsic CTLA-4 signaling has been implicated in T-cell motility and the regulation of CTLA-4 its subcellular localization amongst others. CTLA-4 is well recognized as a key immune checkpoint and has gained significant momentum as a therapeutic target in the field of autoimmunity and cancer. In this chapter, we describe the role of costimulation in immune response induction as well as the main mechanisms by which CTLA-4 can inhibit this process.
Publications found: 40554
Q3
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
Bone Tissue Engineering: From Biomaterials to Clinical Trials
Jagadale S., Damle M., Joshi M.G.
Q3
Advances in Experimental Medicine and Biology
,
2025
,
citations by CoLab: 0
,
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
Open Access
Q3
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
Bioengineering Approaches for Male Infertility: From Microenvironmental Regeneration to in vitro Fertilization
Önen S., Gizer M., Çolak İ.Ö., Korkusuz P.
Q3
Advances in Experimental Medicine and Biology
,
2025
,
citations by CoLab: 0
,
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
Open Access
Q3
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
The Role of Mesenchymal Stem Cell-Derived Exosomes in Skin Regeneration, Tissue Repair, and the Regulation of Hair Follicle Growth
Karimi N., Dinçsoy A.B.
Q3
Advances in Experimental Medicine and Biology
,
2025
,
citations by CoLab: 0
,
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
Open Access
Q3
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
Contact Lenses in Therapeutic Care: A Comprehensive Review of Past Innovations, Present Applications, and Future Directions
Shuaibu A., Topah E.K., Suleman A., D’Esposito F., Tognetto D., Gagliano C., Zeppieri M., Musa M.
Q3
Advances in Experimental Medicine and Biology
,
2025
,
citations by CoLab: 0
,
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
Open Access
Q3
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
Peptide Nanofibers and Skin Regeneration
Tekinay S.H., Tekinay A.B.
Q3
Advances in Experimental Medicine and Biology
,
2025
,
citations by CoLab: 0
,
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
Open Access
Q3
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
Exploring Epigenetic Complexity in Regulation of Hematopoietic Stem Cells Niche: A Mechanistic Journey from Normal to Malignant Hematopoiesis
Yusoff N.A., Abd Hamid Z., Taib I.S., Abdul Razak S.R., Budin S.B.
Q3
Advances in Experimental Medicine and Biology
,
2025
,
citations by CoLab: 0
,
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
Open Access
Q3
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
Cancer and Secretomes: HLA-G and Cancer Puzzle
Sel F.A., Oğuz F.S.
Q3
Advances in Experimental Medicine and Biology
,
2025
,
citations by CoLab: 0
,
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
Open Access
Q3
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
Astrocytes in Primary Familial Brain Calcification (PFBC): Emphasis on the Importance of Induced Pluripotent Stem Cell-Derived Human Astrocyte Models
Kavakli E., Gul N., Begentas O.C., Kiris E.
Q3
Advances in Experimental Medicine and Biology
,
2025
,
citations by CoLab: 0
,
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
Open Access
Q3
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
Hormone Signaling in Breast Development and Cancer
Agnoletto A., Brisken C.
Q3
Advances in Experimental Medicine and Biology
,
2025
,
citations by CoLab: 0
,
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
Open Access
Q3
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
Models for Studying Ductal Carcinoma In Situ Progression
Nair I., Behbod F.
Q3
Advances in Experimental Medicine and Biology
,
2025
,
citations by CoLab: 0
,
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
Open Access
Q3
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
Clinical Implications of Breast Cancer Intrinsic Subtypes
Rios-Hoyo A., Shan N., Karn P.L., Pusztai L.
Q3
Advances in Experimental Medicine and Biology
,
2025
,
citations by CoLab: 0
,
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
Open Access
Q3
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
Immune Microenvironment in Breast Cancer Metastasis
Qian B., Ma R.
Q3
Advances in Experimental Medicine and Biology
,
2025
,
citations by CoLab: 0
,
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
Open Access
Q3
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
RANK/RANKL Signaling Pathway in Breast Development and Cancer
Pérez-Chacón G., Santamaría P.G., Redondo-Pedraza J., González-Suárez E.
Q3
Advances in Experimental Medicine and Biology
,
2025
,
citations by CoLab: 0
,
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
Open Access
Q3
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
The Microenvironment in DCIS and Its Role in Disease Progression
Roozitalab M.R., Prekete N., Allen M., Grose R.P., Louise Jones J.
Q3
Advances in Experimental Medicine and Biology
,
2025
,
citations by CoLab: 0
,
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
Open Access
Q3
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
Metabolic Reprogramming and Adaption in Breast Cancer Progression and Metastasis
Zuo Q., Kang Y.
Q3
Advances in Experimental Medicine and Biology
,
2025
,
citations by CoLab: 0
,
![Springer Nature](/storage/images/resized/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_large.webp)
Open Access
Top-100
Citing journals
1000
2000
3000
4000
5000
6000
7000
8000
9000
|
|
Advances in Experimental Medicine and Biology
8358 citations, 1.87%
|
|
International Journal of Molecular Sciences
8058 citations, 1.8%
|
|
PLoS ONE
4460 citations, 1%
|
|
Scientific Reports
4294 citations, 0.96%
|
|
Journal of Biological Chemistry
3375 citations, 0.75%
|
|
Frontiers in Immunology
2947 citations, 0.66%
|
|
Cells
2196 citations, 0.49%
|
|
Cancers
1967 citations, 0.44%
|
|
Frontiers in Pharmacology
1623 citations, 0.36%
|
|
Frontiers in Oncology
1552 citations, 0.35%
|
|
Journal of Virology
1481 citations, 0.33%
|
|
Nutrients
1445 citations, 0.32%
|
|
Journal of Immunology
1399 citations, 0.31%
|
|
Frontiers in Cell and Developmental Biology
1330 citations, 0.3%
|
|
Frontiers in Physiology
1294 citations, 0.29%
|
|
Proceedings of the National Academy of Sciences of the United States of America
1263 citations, 0.28%
|
|
Molecules
1192 citations, 0.27%
|
|
Biochemical and Biophysical Research Communications
1192 citations, 0.27%
|
|
Brain Research
1169 citations, 0.26%
|
|
Journal of Neurochemistry
1163 citations, 0.26%
|
|
Nature Communications
1072 citations, 0.24%
|
|
Frontiers in Microbiology
1062 citations, 0.24%
|
|
Methods in Molecular Biology
1052 citations, 0.24%
|
|
Journal of Applied Physiology
973 citations, 0.22%
|
|
Biomedicine and Pharmacotherapy
953 citations, 0.21%
|
|
Biomedicines
949 citations, 0.21%
|
|
Life Sciences
938 citations, 0.21%
|
|
Antioxidants
932 citations, 0.21%
|
|
Journal of Clinical Medicine
928 citations, 0.21%
|
|
Annals of the New York Academy of Sciences
905 citations, 0.2%
|
|
Biomolecules
881 citations, 0.2%
|
|
Neuroscience
845 citations, 0.19%
|
|
Journal of Physiology
841 citations, 0.19%
|
|
Frontiers in Endocrinology
818 citations, 0.18%
|
|
Biochemical Pharmacology
806 citations, 0.18%
|
|
European Journal of Pharmacology
780 citations, 0.17%
|
|
Oncotarget
778 citations, 0.17%
|
|
Viruses
765 citations, 0.17%
|
|
Respiratory Physiology and Neurobiology
735 citations, 0.16%
|
|
Frontiers in Genetics
713 citations, 0.16%
|
|
FEBS Letters
700 citations, 0.16%
|
|
Experimental Eye Research
700 citations, 0.16%
|
|
Frontiers in Neuroscience
686 citations, 0.15%
|
|
Journal of Cellular Physiology
678 citations, 0.15%
|
|
Amino Acids
657 citations, 0.15%
|
|
Infection and Immunity
653 citations, 0.15%
|
|
Cellular and Molecular Life Sciences
623 citations, 0.14%
|
|
Neurochemical Research
622 citations, 0.14%
|
|
International Immunopharmacology
617 citations, 0.14%
|
|
Journal of Neuroscience
606 citations, 0.14%
|
|
International Journal of Environmental Research and Public Health
605 citations, 0.14%
|
|
FASEB Journal
595 citations, 0.13%
|
|
Free Radical Biology and Medicine
589 citations, 0.13%
|
|
eLife
586 citations, 0.13%
|
|
British Journal of Pharmacology
584 citations, 0.13%
|
|
Virology
579 citations, 0.13%
|
|
Genes
569 citations, 0.13%
|
|
Blood
548 citations, 0.12%
|
|
American Journal of Physiology - Heart and Circulatory Physiology
547 citations, 0.12%
|
|
Medicine (United States)
546 citations, 0.12%
|
|
Antioxidants and Redox Signaling
540 citations, 0.12%
|
|
Nucleic Acids Research
532 citations, 0.12%
|
|
Heliyon
531 citations, 0.12%
|
|
Molecular Neurobiology
527 citations, 0.12%
|
|
Journal of Neurophysiology
522 citations, 0.12%
|
|
Oncology Letters
520 citations, 0.12%
|
|
Alcoholism: Clinical and Experimental Research
513 citations, 0.11%
|
|
Frontiers in Cellular and Infection Microbiology
508 citations, 0.11%
|
|
Pharmaceutics
507 citations, 0.11%
|
|
Cell Death and Disease
503 citations, 0.11%
|
|
Journal of Agricultural and Food Chemistry
499 citations, 0.11%
|
|
Oxidative Medicine and Cellular Longevity
491 citations, 0.11%
|
|
International Journal of Biological Macromolecules
490 citations, 0.11%
|
|
Journal of Neuroscience Research
485 citations, 0.11%
|
|
Progress in Retinal and Eye Research
480 citations, 0.11%
|
|
American Journal of Physiology - Cell Physiology
480 citations, 0.11%
|
|
Frontiers in Bioengineering and Biotechnology
476 citations, 0.11%
|
|
Archives of Biochemistry and Biophysics
474 citations, 0.11%
|
|
Pharmacology and Therapeutics
471 citations, 0.11%
|
|
Molecular Medicine Reports
468 citations, 0.1%
|
|
Journal of Cerebral Blood Flow and Metabolism
468 citations, 0.1%
|
|
Journal of Molecular Biology
465 citations, 0.1%
|
|
Endocrinology
464 citations, 0.1%
|
|
Pflugers Archiv European Journal of Physiology
463 citations, 0.1%
|
|
Ocular Surface
451 citations, 0.1%
|
|
Frontiers in Cellular Neuroscience
448 citations, 0.1%
|
|
Vaccine
441 citations, 0.1%
|
|
Journal of Nutrition
439 citations, 0.1%
|
|
International Journal of Cancer
438 citations, 0.1%
|
|
Cancer Letters
437 citations, 0.1%
|
|
Microorganisms
437 citations, 0.1%
|
|
Pharmaceuticals
436 citations, 0.1%
|
|
BMC Cancer
436 citations, 0.1%
|
|
PLoS Pathogens
428 citations, 0.1%
|
|
Journal of Lipid Research
428 citations, 0.1%
|
|
Frontiers in Medicine
428 citations, 0.1%
|
|
Neuroscience Letters
420 citations, 0.09%
|
|
BioMed Research International
418 citations, 0.09%
|
|
Journal of Comparative Neurology
418 citations, 0.09%
|
|
Physiological Reviews
417 citations, 0.09%
|
|
Show all (70 more) | |
1000
2000
3000
4000
5000
6000
7000
8000
9000
|
Citing publishers
20000
40000
60000
80000
100000
120000
|
|
Elsevier
100490 citations, 22.46%
|
|
Springer Nature
73390 citations, 16.4%
|
|
Wiley
48082 citations, 10.75%
|
|
MDPI
31714 citations, 7.09%
|
|
Frontiers Media S.A.
20379 citations, 4.56%
|
|
Taylor & Francis
17262 citations, 3.86%
|
|
Ovid Technologies (Wolters Kluwer Health)
8013 citations, 1.79%
|
|
Oxford University Press
6904 citations, 1.54%
|
|
SAGE
6095 citations, 1.36%
|
|
Public Library of Science (PLoS)
6037 citations, 1.35%
|
|
Cold Spring Harbor Laboratory
5934 citations, 1.33%
|
|
American Chemical Society (ACS)
5903 citations, 1.32%
|
|
American Physiological Society
5150 citations, 1.15%
|
|
American Society for Microbiology
4658 citations, 1.04%
|
|
Hindawi Limited
4203 citations, 0.94%
|
|
American Society for Biochemistry and Molecular Biology
3981 citations, 0.89%
|
|
Mary Ann Liebert
3126 citations, 0.7%
|
|
Spandidos Publications
2581 citations, 0.58%
|
|
Royal Society of Chemistry (RSC)
2250 citations, 0.5%
|
|
Bentham Science Publishers Ltd.
2069 citations, 0.46%
|
|
Cambridge University Press
1782 citations, 0.4%
|
|
Proceedings of the National Academy of Sciences (PNAS)
1503 citations, 0.34%
|
|
The American Association of Immunologists
1423 citations, 0.32%
|
|
Institute of Electrical and Electronics Engineers (IEEE)
1366 citations, 0.31%
|
|
American Association for Cancer Research (AACR)
1319 citations, 0.29%
|
|
The Company of Biologists
1294 citations, 0.29%
|
|
Impact Journals
1263 citations, 0.28%
|
|
BMJ
1182 citations, 0.26%
|
|
Pleiades Publishing
1130 citations, 0.25%
|
|
Walter de Gruyter
1105 citations, 0.25%
|
|
Annual Reviews
1028 citations, 0.23%
|
|
Baishideng Publishing Group
982 citations, 0.22%
|
|
The Endocrine Society
936 citations, 0.21%
|
|
S. Karger AG
912 citations, 0.2%
|
|
IOP Publishing
900 citations, 0.2%
|
|
AME Publishing Company
885 citations, 0.2%
|
|
Portland Press
884 citations, 0.2%
|
|
American Society for Nutrition
831 citations, 0.19%
|
|
American Association for the Advancement of Science (AAAS)
806 citations, 0.18%
|
|
Society for Neuroscience
783 citations, 0.18%
|
|
Federation of American Societies for Experimental Biology (FASEB)
717 citations, 0.16%
|
|
American Society of Hematology
697 citations, 0.16%
|
|
eLife Sciences Publications
690 citations, 0.15%
|
|
American Society for Pharmacology and Experimental Therapeutics
681 citations, 0.15%
|
|
IntechOpen
651 citations, 0.15%
|
|
The Royal Society
610 citations, 0.14%
|
|
Rockefeller University Press
589 citations, 0.13%
|
|
588 citations, 0.13%
|
|
American Society for Clinical Investigation
559 citations, 0.12%
|
|
Microbiology Society
557 citations, 0.12%
|
|
Canadian Science Publishing
508 citations, 0.11%
|
|
IOS Press
505 citations, 0.11%
|
|
Georg Thieme Verlag KG
483 citations, 0.11%
|
|
Bioscientifica
456 citations, 0.1%
|
|
SPIE-Intl Soc Optical Eng
431 citations, 0.1%
|
|
Association for Research in Vision and Ophthalmology (ARVO)
414 citations, 0.09%
|
|
American Thoracic Society
413 citations, 0.09%
|
|
PeerJ
384 citations, 0.09%
|
|
367 citations, 0.08%
|
|
AIP Publishing
361 citations, 0.08%
|
|
Research Square Platform LLC
355 citations, 0.08%
|
|
European Molecular Biology Organization
344 citations, 0.08%
|
|
Society for the Study of Reproduction
342 citations, 0.08%
|
|
Acoustical Society of America (ASA)
334 citations, 0.07%
|
|
Optica Publishing Group
308 citations, 0.07%
|
|
JMIR Publications
284 citations, 0.06%
|
|
American Diabetes Association
281 citations, 0.06%
|
|
World Scientific
278 citations, 0.06%
|
|
F1000 Research
267 citations, 0.06%
|
|
Biophysical Society
262 citations, 0.06%
|
|
Massachusetts Medical Society
262 citations, 0.06%
|
|
Pharmaceutical Society of Japan
255 citations, 0.06%
|
|
SciELO
247 citations, 0.06%
|
|
IGI Global
237 citations, 0.05%
|
|
Medknow
234 citations, 0.05%
|
|
Environmental Health Perspectives
231 citations, 0.05%
|
|
OAE Publishing Inc.
229 citations, 0.05%
|
|
Media Sphere Publishing House
215 citations, 0.05%
|
|
American Society for Cell Biology (ASCB)
204 citations, 0.05%
|
|
Scientific Research Publishing
199 citations, 0.04%
|
|
Hans Publishers
196 citations, 0.04%
|
|
American Society of Animal Science
181 citations, 0.04%
|
|
CSIRO Publishing
163 citations, 0.04%
|
|
Journal of Neurosurgery Publishing Group (JNSPG)
161 citations, 0.04%
|
|
Eco-Vector LLC
158 citations, 0.04%
|
|
American Society of Clinical Oncology (ASCO)
157 citations, 0.04%
|
|
154 citations, 0.03%
|
|
King Saud University
143 citations, 0.03%
|
|
American Academy of Pediatrics
134 citations, 0.03%
|
|
American Medical Association (AMA)
122 citations, 0.03%
|
|
European Respiratory Society (ERS)
121 citations, 0.03%
|
|
International Union of Crystallography (IUCr)
120 citations, 0.03%
|
|
Pharmaceutical Society of Korea
119 citations, 0.03%
|
|
EDP Sciences
117 citations, 0.03%
|
|
Akademiai Kiado
109 citations, 0.02%
|
|
Radiation Research Society
108 citations, 0.02%
|
|
Mark Allen Group
105 citations, 0.02%
|
|
American Veterinary Medical Association
102 citations, 0.02%
|
|
American Scientific Publishers
101 citations, 0.02%
|
|
American Society of Nephrology
101 citations, 0.02%
|
|
Show all (70 more) | |
20000
40000
60000
80000
100000
120000
|
Publishing organizations
100
200
300
400
500
600
|
|
Harvard University
582 publications, 1.44%
|
|
University of Pennsylvania
522 publications, 1.29%
|
|
Johns Hopkins University
363 publications, 0.9%
|
|
University of Tokyo
296 publications, 0.73%
|
|
University of Washington
270 publications, 0.67%
|
|
University of Toronto
260 publications, 0.64%
|
|
Columbia University
256 publications, 0.63%
|
|
University of California, San Diego
256 publications, 0.63%
|
|
University of California, Los Angeles
249 publications, 0.61%
|
|
University of California, San Francisco
249 publications, 0.61%
|
|
Case Western Reserve University
247 publications, 0.61%
|
|
University of Alabama at Birmingham
243 publications, 0.6%
|
|
Ludwig Maximilian University of Munich
237 publications, 0.58%
|
|
Medical University of Warsaw
237 publications, 0.58%
|
|
University College London
228 publications, 0.56%
|
|
University of Michigan
224 publications, 0.55%
|
|
Karolinska Institute
217 publications, 0.54%
|
|
Baylor College of Medicine
200 publications, 0.49%
|
|
University of Southern California
198 publications, 0.49%
|
|
University of Florida
196 publications, 0.48%
|
|
University of Wisconsin–Madison
195 publications, 0.48%
|
|
Osaka University
190 publications, 0.47%
|
|
Cornell University
188 publications, 0.46%
|
|
University of Oxford
186 publications, 0.46%
|
|
University of Minnesota
184 publications, 0.45%
|
|
Yale University
181 publications, 0.45%
|
|
Washington University in St. Louis
180 publications, 0.44%
|
|
Massachusetts General Hospital
172 publications, 0.42%
|
|
McGill University
170 publications, 0.42%
|
|
Stanford University
166 publications, 0.41%
|
|
University of North Carolina at Chapel Hill
166 publications, 0.41%
|
|
University of California, Davis
163 publications, 0.4%
|
|
Johannes Gutenberg University Mainz
163 publications, 0.4%
|
|
University of Milan
160 publications, 0.39%
|
|
University of Chicago
154 publications, 0.38%
|
|
Ionian University
154 publications, 0.38%
|
|
University of Texas MD Anderson Cancer Center
154 publications, 0.38%
|
|
University of Cambridge
150 publications, 0.37%
|
|
Universidade Estadual de Campinas
148 publications, 0.36%
|
|
University of Arizona
147 publications, 0.36%
|
|
Mashhad University of Medical Sciences
142 publications, 0.35%
|
|
Duke University Hospital
140 publications, 0.35%
|
|
Emory University
136 publications, 0.34%
|
|
National Cancer Institute
136 publications, 0.34%
|
|
National and Kapodistrian University of Athens
134 publications, 0.33%
|
|
University of Miami
134 publications, 0.33%
|
|
Sapienza University of Rome
133 publications, 0.33%
|
|
Imperial College London
131 publications, 0.32%
|
|
Erasmus University Rotterdam
131 publications, 0.32%
|
|
Heidelberg University
130 publications, 0.32%
|
|
University of Oklahoma Health Sciences Center
130 publications, 0.32%
|
|
Albert Einstein College of Medicine
129 publications, 0.32%
|
|
Howard Hughes Medical Institute
127 publications, 0.31%
|
|
University of Colorado Anschutz Medical Campus
124 publications, 0.31%
|
|
Vrije Universiteit Amsterdam
123 publications, 0.3%
|
|
Brigham and Women's Hospital
122 publications, 0.3%
|
|
University of Amsterdam
121 publications, 0.3%
|
|
University of Calgary
121 publications, 0.3%
|
|
University of Rochester
121 publications, 0.3%
|
|
Hebrew University of Jerusalem
120 publications, 0.3%
|
|
Northwestern University
119 publications, 0.29%
|
|
Wayne State University
119 publications, 0.29%
|
|
Mayo Clinic
119 publications, 0.29%
|
|
Kyoto University
118 publications, 0.29%
|
|
University of Florence
117 publications, 0.29%
|
|
Radboud University Nijmegen
116 publications, 0.29%
|
|
University of Zurich
116 publications, 0.29%
|
|
University of Padua
116 publications, 0.29%
|
|
University of Glasgow
116 publications, 0.29%
|
|
Hokkaido University
116 publications, 0.29%
|
|
University of Texas Medical Branch
115 publications, 0.28%
|
|
University of Bern
114 publications, 0.28%
|
|
Amsterdam University Medical Center
114 publications, 0.28%
|
|
Weizmann Institute of Science
113 publications, 0.28%
|
|
Texas A&M University
113 publications, 0.28%
|
|
University of Utah
113 publications, 0.28%
|
|
New York University
112 publications, 0.28%
|
|
Katholieke Universiteit Leuven
111 publications, 0.27%
|
|
Vanderbilt University
110 publications, 0.27%
|
|
University of Alberta
110 publications, 0.27%
|
|
Peking University
109 publications, 0.27%
|
|
University of Copenhagen
109 publications, 0.27%
|
|
Pennsylvania State University
109 publications, 0.27%
|
|
University of Texas Southwestern Medical Center
108 publications, 0.27%
|
|
Fudan University
107 publications, 0.26%
|
|
University of Melbourne
107 publications, 0.26%
|
|
Rutgers, The State University of New Jersey
107 publications, 0.26%
|
|
University of South Florida
107 publications, 0.26%
|
|
Boston University
106 publications, 0.26%
|
|
Istituti di Ricovero e Cura a Carattere Scientifico
104 publications, 0.26%
|
|
Charité - Universitätsmedizin Berlin
104 publications, 0.26%
|
|
Tehran University of Medical Sciences
103 publications, 0.25%
|
|
Tel Aviv University
103 publications, 0.25%
|
|
University of British Columbia
103 publications, 0.25%
|
|
Lund University
102 publications, 0.25%
|
|
Wrocław Medical University
102 publications, 0.25%
|
|
Ohio State University
101 publications, 0.25%
|
|
Nihon University
100 publications, 0.25%
|
|
Temple University
100 publications, 0.25%
|
|
University of Gothenburg
96 publications, 0.24%
|
|
Show all (70 more) | |
100
200
300
400
500
600
|
Publishing organizations in 5 years
20
40
60
80
100
120
140
|
|
Mashhad University of Medical Sciences
137 publications, 3.03%
|
|
Ionian University
108 publications, 2.39%
|
|
Tehran University of Medical Sciences
95 publications, 2.1%
|
|
National and Kapodistrian University of Athens
93 publications, 2.05%
|
|
Universidade Estadual de Campinas
78 publications, 1.72%
|
|
Peking University
57 publications, 1.26%
|
|
University of Texas MD Anderson Cancer Center
55 publications, 1.22%
|
|
Harvard University
52 publications, 1.15%
|
|
Texas A&M University
51 publications, 1.13%
|
|
Islamic Azad University of Quchan
50 publications, 1.1%
|
|
Istituti di Ricovero e Cura a Carattere Scientifico
48 publications, 1.06%
|
|
Children's Hospital Agia Sophia
48 publications, 1.06%
|
|
Johns Hopkins University
47 publications, 1.04%
|
|
Fudan University
46 publications, 1.02%
|
|
Shanghai Jiao Tong University
45 publications, 0.99%
|
|
Chinese Academy of Medical Sciences & Peking Union Medical College
44 publications, 0.97%
|
|
University of Thessaly
42 publications, 0.93%
|
|
Shahid Beheshti University of Medical Sciences and Health Services
41 publications, 0.91%
|
|
Universal Scientific Education and Research Network
39 publications, 0.86%
|
|
Agricultural University of Athens
39 publications, 0.86%
|
|
University of West Attica
38 publications, 0.84%
|
|
University of Hull
36 publications, 0.8%
|
|
Baqiyatallah University of Medical Sciences
35 publications, 0.77%
|
|
Academy of Athens
35 publications, 0.77%
|
|
Charité - Universitätsmedizin Berlin
33 publications, 0.73%
|
|
University of Glasgow
32 publications, 0.71%
|
|
Gazi University
31 publications, 0.68%
|
|
Isfahan University of Medical Sciences
31 publications, 0.68%
|
|
Seoul National University
31 publications, 0.68%
|
|
Imperial College London
27 publications, 0.6%
|
|
University of Tokyo
27 publications, 0.6%
|
|
University of Pennsylvania
27 publications, 0.6%
|
|
University of Toronto
27 publications, 0.6%
|
|
Sichuan University
26 publications, 0.57%
|
|
Ludwig Maximilian University of Munich
26 publications, 0.57%
|
|
Mayo Clinic
26 publications, 0.57%
|
|
University Hospital of Zürich
25 publications, 0.55%
|
|
Capital Medical University
24 publications, 0.53%
|
|
NOVA University Lisbon
24 publications, 0.53%
|
|
Karolinska Institute
23 publications, 0.51%
|
|
Cornell University
23 publications, 0.51%
|
|
Columbia University
23 publications, 0.51%
|
|
Massachusetts General Hospital
23 publications, 0.51%
|
|
University of California, San Francisco
23 publications, 0.51%
|
|
Hamedan University of Medical Sciences
22 publications, 0.49%
|
|
Zhejiang University
22 publications, 0.49%
|
|
Kyoto University
22 publications, 0.49%
|
|
Hellenic Open University
22 publications, 0.49%
|
|
University of Patras
21 publications, 0.46%
|
|
Icahn School of Medicine at Mount Sinai
21 publications, 0.46%
|
|
University of Western Australia
20 publications, 0.44%
|
|
Case Western Reserve University
20 publications, 0.44%
|
|
Aristotle University of Thessaloniki
20 publications, 0.44%
|
|
Universidad Andrés Bello
20 publications, 0.44%
|
|
University of Alabama at Birmingham
20 publications, 0.44%
|
|
University of Melbourne
19 publications, 0.42%
|
|
Korea University
19 publications, 0.42%
|
|
Southern Medical University
18 publications, 0.4%
|
|
University of California, San Diego
18 publications, 0.4%
|
|
Iran University of Medical Sciences
17 publications, 0.38%
|
|
University College London
17 publications, 0.38%
|
|
University of Cambridge
17 publications, 0.38%
|
|
Sorbonne University
17 publications, 0.38%
|
|
Beijing Normal University
16 publications, 0.35%
|
|
University of Lisbon
16 publications, 0.35%
|
|
Sapienza University of Rome
16 publications, 0.35%
|
|
University of Zurich
16 publications, 0.35%
|
|
Konkuk University
16 publications, 0.35%
|
|
University of Illinois at Chicago
16 publications, 0.35%
|
|
Chonbuk National University
16 publications, 0.35%
|
|
Wrocław Medical University
16 publications, 0.35%
|
|
Assam University
15 publications, 0.33%
|
|
University of Bern
15 publications, 0.33%
|
|
Sun Yat-sen University
15 publications, 0.33%
|
|
University of Queensland
15 publications, 0.33%
|
|
Osaka University
15 publications, 0.33%
|
|
University of Ioannina
15 publications, 0.33%
|
|
University of Wisconsin–Madison
15 publications, 0.33%
|
|
Privolzhsky Research Medical University
14 publications, 0.31%
|
|
Academic Center for Education Culture and Research
14 publications, 0.31%
|
|
Ahvaz Jundishapur University of Medical Sciences
14 publications, 0.31%
|
|
Kerman University of Medical Sciences
14 publications, 0.31%
|
|
Shanghai University
14 publications, 0.31%
|
|
Soochow University (Suzhou)
14 publications, 0.31%
|
|
University of the Witwatersrand
14 publications, 0.31%
|
|
Stanford University
14 publications, 0.31%
|
|
Gachon University
14 publications, 0.31%
|
|
University of California, Los Angeles
14 publications, 0.31%
|
|
Baylor College of Medicine
14 publications, 0.31%
|
|
Emory University
14 publications, 0.31%
|
|
Cleveland Clinic
14 publications, 0.31%
|
|
Vietnam National University Ho Chi Minh City
13 publications, 0.29%
|
|
Tongji University
13 publications, 0.29%
|
|
University of Bari Aldo Moro
13 publications, 0.29%
|
|
Brigham and Women's Hospital
13 publications, 0.29%
|
|
University of California, Davis
13 publications, 0.29%
|
|
Hanbat National University
13 publications, 0.29%
|
|
Shandong University
13 publications, 0.29%
|
|
Newcastle University
13 publications, 0.29%
|
|
Otto-von-Guericke University Magdeburg
13 publications, 0.29%
|
|
Show all (70 more) | |
20
40
60
80
100
120
140
|
Publishing countries
2000
4000
6000
8000
10000
12000
14000
16000
18000
|
|
USA
|
USA, 16118, 39.74%
USA
16118 publications, 39.74%
|
United Kingdom
|
United Kingdom, 3361, 8.29%
United Kingdom
3361 publications, 8.29%
|
Germany
|
Germany, 3194, 7.88%
Germany
3194 publications, 7.88%
|
Japan
|
Japan, 2748, 6.78%
Japan
2748 publications, 6.78%
|
Italy
|
Italy, 1899, 4.68%
Italy
1899 publications, 4.68%
|
Canada
|
Canada, 1702, 4.2%
Canada
1702 publications, 4.2%
|
China
|
China, 1591, 3.92%
China
1591 publications, 3.92%
|
France
|
France, 1477, 3.64%
France
1477 publications, 3.64%
|
Netherlands
|
Netherlands, 1223, 3.02%
Netherlands
1223 publications, 3.02%
|
Poland
|
Poland, 949, 2.34%
Poland
949 publications, 2.34%
|
Australia
|
Australia, 919, 2.27%
Australia
919 publications, 2.27%
|
Spain
|
Spain, 786, 1.94%
Spain
786 publications, 1.94%
|
Sweden
|
Sweden, 774, 1.91%
Sweden
774 publications, 1.91%
|
Switzerland
|
Switzerland, 741, 1.83%
Switzerland
741 publications, 1.83%
|
Belgium
|
Belgium, 535, 1.32%
Belgium
535 publications, 1.32%
|
Israel
|
Israel, 527, 1.3%
Israel
527 publications, 1.3%
|
Greece
|
Greece, 504, 1.24%
Greece
504 publications, 1.24%
|
Brazil
|
Brazil, 447, 1.1%
Brazil
447 publications, 1.1%
|
Republic of Korea
|
Republic of Korea, 439, 1.08%
Republic of Korea
439 publications, 1.08%
|
India
|
India, 408, 1.01%
India
408 publications, 1.01%
|
Denmark
|
Denmark, 329, 0.81%
Denmark
329 publications, 0.81%
|
Austria
|
Austria, 314, 0.77%
Austria
314 publications, 0.77%
|
Iran
|
Iran, 287, 0.71%
Iran
287 publications, 0.71%
|
Russia
|
Russia, 281, 0.69%
Russia
281 publications, 0.69%
|
Turkey
|
Turkey, 258, 0.64%
Turkey
258 publications, 0.64%
|
Finland
|
Finland, 249, 0.61%
Finland
249 publications, 0.61%
|
Portugal
|
Portugal, 247, 0.61%
Portugal
247 publications, 0.61%
|
Ireland
|
Ireland, 210, 0.52%
Ireland
210 publications, 0.52%
|
Norway
|
Norway, 193, 0.48%
Norway
193 publications, 0.48%
|
Mexico
|
Mexico, 168, 0.41%
Mexico
168 publications, 0.41%
|
Hungary
|
Hungary, 161, 0.4%
Hungary
161 publications, 0.4%
|
Chile
|
Chile, 155, 0.38%
Chile
155 publications, 0.38%
|
Czech Republic
|
Czech Republic, 136, 0.34%
Czech Republic
136 publications, 0.34%
|
New Zealand
|
New Zealand, 129, 0.32%
New Zealand
129 publications, 0.32%
|
South Africa
|
South Africa, 116, 0.29%
South Africa
116 publications, 0.29%
|
Argentina
|
Argentina, 104, 0.26%
Argentina
104 publications, 0.26%
|
Slovakia
|
Slovakia, 101, 0.25%
Slovakia
101 publications, 0.25%
|
Singapore
|
Singapore, 81, 0.2%
Singapore
81 publications, 0.2%
|
Romania
|
Romania, 77, 0.19%
Romania
77 publications, 0.19%
|
Malaysia
|
Malaysia, 60, 0.15%
Malaysia
60 publications, 0.15%
|
Egypt
|
Egypt, 59, 0.15%
Egypt
59 publications, 0.15%
|
Thailand
|
Thailand, 59, 0.15%
Thailand
59 publications, 0.15%
|
Slovenia
|
Slovenia, 53, 0.13%
Slovenia
53 publications, 0.13%
|
Czechoslovakia
|
Czechoslovakia, 46, 0.11%
Czechoslovakia
46 publications, 0.11%
|
Saudi Arabia
|
Saudi Arabia, 45, 0.11%
Saudi Arabia
45 publications, 0.11%
|
Yugoslavia
|
Yugoslavia, 45, 0.11%
Yugoslavia
45 publications, 0.11%
|
Serbia
|
Serbia, 42, 0.1%
Serbia
42 publications, 0.1%
|
Bulgaria
|
Bulgaria, 41, 0.1%
Bulgaria
41 publications, 0.1%
|
Croatia
|
Croatia, 41, 0.1%
Croatia
41 publications, 0.1%
|
Pakistan
|
Pakistan, 39, 0.1%
Pakistan
39 publications, 0.1%
|
USSR
|
USSR, 39, 0.1%
USSR
39 publications, 0.1%
|
Indonesia
|
Indonesia, 34, 0.08%
Indonesia
34 publications, 0.08%
|
Vietnam
|
Vietnam, 31, 0.08%
Vietnam
31 publications, 0.08%
|
Ukraine
|
Ukraine, 30, 0.07%
Ukraine
30 publications, 0.07%
|
UAE
|
UAE, 27, 0.07%
UAE
27 publications, 0.07%
|
Lebanon
|
Lebanon, 25, 0.06%
Lebanon
25 publications, 0.06%
|
Kenya
|
Kenya, 23, 0.06%
Kenya
23 publications, 0.06%
|
Venezuela
|
Venezuela, 22, 0.05%
Venezuela
22 publications, 0.05%
|
Uruguay
|
Uruguay, 20, 0.05%
Uruguay
20 publications, 0.05%
|
Colombia
|
Colombia, 18, 0.04%
Colombia
18 publications, 0.04%
|
Lithuania
|
Lithuania, 18, 0.04%
Lithuania
18 publications, 0.04%
|
Nigeria
|
Nigeria, 18, 0.04%
Nigeria
18 publications, 0.04%
|
Latvia
|
Latvia, 17, 0.04%
Latvia
17 publications, 0.04%
|
Nepal
|
Nepal, 17, 0.04%
Nepal
17 publications, 0.04%
|
Cyprus
|
Cyprus, 16, 0.04%
Cyprus
16 publications, 0.04%
|
Tunisia
|
Tunisia, 15, 0.04%
Tunisia
15 publications, 0.04%
|
Cuba
|
Cuba, 13, 0.03%
Cuba
13 publications, 0.03%
|
Estonia
|
Estonia, 12, 0.03%
Estonia
12 publications, 0.03%
|
Iraq
|
Iraq, 11, 0.03%
Iraq
11 publications, 0.03%
|
Moldova
|
Moldova, 11, 0.03%
Moldova
11 publications, 0.03%
|
Georgia
|
Georgia, 10, 0.02%
Georgia
10 publications, 0.02%
|
Qatar
|
Qatar, 10, 0.02%
Qatar
10 publications, 0.02%
|
Puerto Rico
|
Puerto Rico, 10, 0.02%
Puerto Rico
10 publications, 0.02%
|
Bangladesh
|
Bangladesh, 9, 0.02%
Bangladesh
9 publications, 0.02%
|
Luxembourg
|
Luxembourg, 9, 0.02%
Luxembourg
9 publications, 0.02%
|
Peru
|
Peru, 9, 0.02%
Peru
9 publications, 0.02%
|
Kazakhstan
|
Kazakhstan, 8, 0.02%
Kazakhstan
8 publications, 0.02%
|
Armenia
|
Armenia, 7, 0.02%
Armenia
7 publications, 0.02%
|
Bolivia
|
Bolivia, 7, 0.02%
Bolivia
7 publications, 0.02%
|
Ghana
|
Ghana, 7, 0.02%
Ghana
7 publications, 0.02%
|
Jordan
|
Jordan, 6, 0.01%
Jordan
6 publications, 0.01%
|
Iceland
|
Iceland, 6, 0.01%
Iceland
6 publications, 0.01%
|
Morocco
|
Morocco, 6, 0.01%
Morocco
6 publications, 0.01%
|
Panama
|
Panama, 6, 0.01%
Panama
6 publications, 0.01%
|
Gambia
|
Gambia, 5, 0.01%
Gambia
5 publications, 0.01%
|
Philippines
|
Philippines, 5, 0.01%
Philippines
5 publications, 0.01%
|
Sri Lanka
|
Sri Lanka, 5, 0.01%
Sri Lanka
5 publications, 0.01%
|
Ecuador
|
Ecuador, 5, 0.01%
Ecuador
5 publications, 0.01%
|
Belarus
|
Belarus, 4, 0.01%
Belarus
4 publications, 0.01%
|
Guatemala
|
Guatemala, 4, 0.01%
Guatemala
4 publications, 0.01%
|
Costa Rica
|
Costa Rica, 4, 0.01%
Costa Rica
4 publications, 0.01%
|
Uzbekistan
|
Uzbekistan, 4, 0.01%
Uzbekistan
4 publications, 0.01%
|
Ethiopia
|
Ethiopia, 4, 0.01%
Ethiopia
4 publications, 0.01%
|
Kosovo
|
Kosovo, 4, 0.01%
Kosovo
4 publications, 0.01%
|
Azerbaijan
|
Azerbaijan, 3, 0.01%
Azerbaijan
3 publications, 0.01%
|
Algeria
|
Algeria, 3, 0.01%
Algeria
3 publications, 0.01%
|
Bosnia and Herzegovina
|
Bosnia and Herzegovina, 3, 0.01%
Bosnia and Herzegovina
3 publications, 0.01%
|
Gabon
|
Gabon, 3, 0.01%
Gabon
3 publications, 0.01%
|
Zambia
|
Zambia, 3, 0.01%
Zambia
3 publications, 0.01%
|
Kuwait
|
Kuwait, 3, 0.01%
Kuwait
3 publications, 0.01%
|
Show all (70 more) | |
2000
4000
6000
8000
10000
12000
14000
16000
18000
|
Publishing countries in 5 years
200
400
600
800
1000
1200
|
|
USA
|
USA, 1175, 25.96%
USA
1175 publications, 25.96%
|
China
|
China, 541, 11.95%
China
541 publications, 11.95%
|
United Kingdom
|
United Kingdom, 318, 7.03%
United Kingdom
318 publications, 7.03%
|
Greece
|
Greece, 317, 7%
Greece
317 publications, 7%
|
Iran
|
Iran, 241, 5.32%
Iran
241 publications, 5.32%
|
Germany
|
Germany, 240, 5.3%
Germany
240 publications, 5.3%
|
Japan
|
Japan, 230, 5.08%
Japan
230 publications, 5.08%
|
Italy
|
Italy, 217, 4.79%
Italy
217 publications, 4.79%
|
Brazil
|
Brazil, 170, 3.76%
Brazil
170 publications, 3.76%
|
Poland
|
Poland, 161, 3.56%
Poland
161 publications, 3.56%
|
India
|
India, 152, 3.36%
India
152 publications, 3.36%
|
Republic of Korea
|
Republic of Korea, 134, 2.96%
Republic of Korea
134 publications, 2.96%
|
Spain
|
Spain, 131, 2.89%
Spain
131 publications, 2.89%
|
Australia
|
Australia, 130, 2.87%
Australia
130 publications, 2.87%
|
Canada
|
Canada, 127, 2.81%
Canada
127 publications, 2.81%
|
France
|
France, 112, 2.47%
France
112 publications, 2.47%
|
Turkey
|
Turkey, 107, 2.36%
Turkey
107 publications, 2.36%
|
Portugal
|
Portugal, 86, 1.9%
Portugal
86 publications, 1.9%
|
Switzerland
|
Switzerland, 73, 1.61%
Switzerland
73 publications, 1.61%
|
Netherlands
|
Netherlands, 62, 1.37%
Netherlands
62 publications, 1.37%
|
Chile
|
Chile, 52, 1.15%
Chile
52 publications, 1.15%
|
Sweden
|
Sweden, 46, 1.02%
Sweden
46 publications, 1.02%
|
South Africa
|
South Africa, 46, 1.02%
South Africa
46 publications, 1.02%
|
Russia
|
Russia, 43, 0.95%
Russia
43 publications, 0.95%
|
Belgium
|
Belgium, 40, 0.88%
Belgium
40 publications, 0.88%
|
Finland
|
Finland, 34, 0.75%
Finland
34 publications, 0.75%
|
Ireland
|
Ireland, 29, 0.64%
Ireland
29 publications, 0.64%
|
Mexico
|
Mexico, 29, 0.64%
Mexico
29 publications, 0.64%
|
Israel
|
Israel, 27, 0.6%
Israel
27 publications, 0.6%
|
Egypt
|
Egypt, 25, 0.55%
Egypt
25 publications, 0.55%
|
Norway
|
Norway, 25, 0.55%
Norway
25 publications, 0.55%
|
Denmark
|
Denmark, 19, 0.42%
Denmark
19 publications, 0.42%
|
Malaysia
|
Malaysia, 18, 0.4%
Malaysia
18 publications, 0.4%
|
Austria
|
Austria, 16, 0.35%
Austria
16 publications, 0.35%
|
Saudi Arabia
|
Saudi Arabia, 16, 0.35%
Saudi Arabia
16 publications, 0.35%
|
Singapore
|
Singapore, 14, 0.31%
Singapore
14 publications, 0.31%
|
Vietnam
|
Vietnam, 13, 0.29%
Vietnam
13 publications, 0.29%
|
Colombia
|
Colombia, 12, 0.27%
Colombia
12 publications, 0.27%
|
Croatia
|
Croatia, 11, 0.24%
Croatia
11 publications, 0.24%
|
Cyprus
|
Cyprus, 10, 0.22%
Cyprus
10 publications, 0.22%
|
Nigeria
|
Nigeria, 10, 0.22%
Nigeria
10 publications, 0.22%
|
Thailand
|
Thailand, 10, 0.22%
Thailand
10 publications, 0.22%
|
Czech Republic
|
Czech Republic, 10, 0.22%
Czech Republic
10 publications, 0.22%
|
Iraq
|
Iraq, 9, 0.2%
Iraq
9 publications, 0.2%
|
Lithuania
|
Lithuania, 9, 0.2%
Lithuania
9 publications, 0.2%
|
New Zealand
|
New Zealand, 9, 0.2%
New Zealand
9 publications, 0.2%
|
UAE
|
UAE, 9, 0.2%
UAE
9 publications, 0.2%
|
Serbia
|
Serbia, 9, 0.2%
Serbia
9 publications, 0.2%
|
Slovenia
|
Slovenia, 9, 0.2%
Slovenia
9 publications, 0.2%
|
Bulgaria
|
Bulgaria, 8, 0.18%
Bulgaria
8 publications, 0.18%
|
Hungary
|
Hungary, 8, 0.18%
Hungary
8 publications, 0.18%
|
Qatar
|
Qatar, 8, 0.18%
Qatar
8 publications, 0.18%
|
Lebanon
|
Lebanon, 8, 0.18%
Lebanon
8 publications, 0.18%
|
Romania
|
Romania, 8, 0.18%
Romania
8 publications, 0.18%
|
Ukraine
|
Ukraine, 7, 0.15%
Ukraine
7 publications, 0.15%
|
Argentina
|
Argentina, 7, 0.15%
Argentina
7 publications, 0.15%
|
Nepal
|
Nepal, 7, 0.15%
Nepal
7 publications, 0.15%
|
Tunisia
|
Tunisia, 7, 0.15%
Tunisia
7 publications, 0.15%
|
Slovakia
|
Slovakia, 6, 0.13%
Slovakia
6 publications, 0.13%
|
Kazakhstan
|
Kazakhstan, 5, 0.11%
Kazakhstan
5 publications, 0.11%
|
Bangladesh
|
Bangladesh, 5, 0.11%
Bangladesh
5 publications, 0.11%
|
Indonesia
|
Indonesia, 5, 0.11%
Indonesia
5 publications, 0.11%
|
Uruguay
|
Uruguay, 5, 0.11%
Uruguay
5 publications, 0.11%
|
Jordan
|
Jordan, 4, 0.09%
Jordan
4 publications, 0.09%
|
Morocco
|
Morocco, 4, 0.09%
Morocco
4 publications, 0.09%
|
Peru
|
Peru, 4, 0.09%
Peru
4 publications, 0.09%
|
Ethiopia
|
Ethiopia, 4, 0.09%
Ethiopia
4 publications, 0.09%
|
Estonia
|
Estonia, 3, 0.07%
Estonia
3 publications, 0.07%
|
Ghana
|
Ghana, 3, 0.07%
Ghana
3 publications, 0.07%
|
Pakistan
|
Pakistan, 3, 0.07%
Pakistan
3 publications, 0.07%
|
Ecuador
|
Ecuador, 3, 0.07%
Ecuador
3 publications, 0.07%
|
Afghanistan
|
Afghanistan, 2, 0.04%
Afghanistan
2 publications, 0.04%
|
Bahrain
|
Bahrain, 2, 0.04%
Bahrain
2 publications, 0.04%
|
Venezuela
|
Venezuela, 2, 0.04%
Venezuela
2 publications, 0.04%
|
Kenya
|
Kenya, 2, 0.04%
Kenya
2 publications, 0.04%
|
Costa Rica
|
Costa Rica, 2, 0.04%
Costa Rica
2 publications, 0.04%
|
Latvia
|
Latvia, 2, 0.04%
Latvia
2 publications, 0.04%
|
Syria
|
Syria, 2, 0.04%
Syria
2 publications, 0.04%
|
Belarus
|
Belarus, 1, 0.02%
Belarus
1 publication, 0.02%
|
Azerbaijan
|
Azerbaijan, 1, 0.02%
Azerbaijan
1 publication, 0.02%
|
Algeria
|
Algeria, 1, 0.02%
Algeria
1 publication, 0.02%
|
Antigua and Barbuda
|
Antigua and Barbuda, 1, 0.02%
Antigua and Barbuda
1 publication, 0.02%
|
Bosnia and Herzegovina
|
Bosnia and Herzegovina, 1, 0.02%
Bosnia and Herzegovina
1 publication, 0.02%
|
Zimbabwe
|
Zimbabwe, 1, 0.02%
Zimbabwe
1 publication, 0.02%
|
Yemen
|
Yemen, 1, 0.02%
Yemen
1 publication, 0.02%
|
Cuba
|
Cuba, 1, 0.02%
Cuba
1 publication, 0.02%
|
Kuwait
|
Kuwait, 1, 0.02%
Kuwait
1 publication, 0.02%
|
Luxembourg
|
Luxembourg, 1, 0.02%
Luxembourg
1 publication, 0.02%
|
Moldova
|
Moldova, 1, 0.02%
Moldova
1 publication, 0.02%
|
Monaco
|
Monaco, 1, 0.02%
Monaco
1 publication, 0.02%
|
Oman
|
Oman, 1, 0.02%
Oman
1 publication, 0.02%
|
Panama
|
Panama, 1, 0.02%
Panama
1 publication, 0.02%
|
Tanzania
|
Tanzania, 1, 0.02%
Tanzania
1 publication, 0.02%
|
Uganda
|
Uganda, 1, 0.02%
Uganda
1 publication, 0.02%
|
Philippines
|
Philippines, 1, 0.02%
Philippines
1 publication, 0.02%
|
Kosovo
|
Kosovo, 1, 0.02%
Kosovo
1 publication, 0.02%
|
Show all (66 more) | |
200
400
600
800
1000
1200
|
5 profile journal articles
Ferran Christiane
49 publications,
1 334 citations
h-index: 23
5 profile journal articles
Rybak Ilya
![Drexel University](/storage/images/resized/I1NG5t9ochuSIZ6ZsVrLCkCJz4NxxeFTDpPsRJ2q_small_thumb.webp)
Drexel University
139 publications,
6 433 citations
h-index: 45
3 profile journal articles
Knirel Yuriy
DSc in Chemistry, Professor
![N.D. Zelinsky Institute of Organic Chemistry of the Russian Academy of Sciences](/storage/images/resized/EL1mVPpMGn39TSrywSTQs3ya63SNR5D9GdY9PbhT_small_thumb.webp)
N.D. Zelinsky Institute of Organic Chemistry of the Russian Academy of Sciences
731 publications,
15 243 citations
h-index: 53
3 profile journal articles
Abdurashitov Arkady
![Skolkovo Institute of Science and Technology](/storage/images/resized/LqUPG0Ipu7ZHhte9r4gFTTptxQfmb37QHBQlKGJe_small_thumb.webp)
Skolkovo Institute of Science and Technology
81 publications,
689 citations
h-index: 15
2 profile journal articles
Ermakov Alexey
🥼 🤝
DSc in Biological/biomedical sciences, Professor
![Don State Technical University](/storage/images/resized/O2PGnFZ0ZNtGrN2dznWdsOK9PL3qDpNt1O8QxG52_small_thumb.webp)
Don State Technical University
70 publications,
552 citations
h-index: 13
Research interests
Animal diseases
Infectious diseases of animals
Veterinary
Zoonoses
2 profile journal articles
Chunfeng (Alfred)
12 publications,
320 citations
h-index: 3
2 profile journal articles
Adhikari Rameshwar
176 publications,
2 750 citations
h-index: 28
2 profile journal articles
Marselli Lorella
164 publications,
10 458 citations
h-index: 54
1 profile journal article
Komleva Yulia
49 publications,
850 citations
h-index: 17
1 profile journal article
Emran Talha
![Brown University](/storage/images/resized/KWu5BzUiM6BQb5bCbIpU15YJjYQB2Tiw2w2piiBJ_small_thumb.webp)
Brown University
![BGC Trust University Bangladesh](/storage/images/resized/07mTj6BQdB4HeiAgco8WQXkGvKRRVuZWVz60S1o7_small_thumb.webp)
BGC Trust University Bangladesh
544 publications,
13 497 citations
h-index: 58
1 profile journal article
PhD in Chemistry
![G. B. Elyakov Pacific Institute of Bioorganic Chemistry of the Far Eastern Branch of the Russian Academy of Sciences](/storage/images/resized/NSnBPBb9hWBKaJIoIFXw3GdYcHGnwoHtnkdAYlir_small_thumb.webp)
G. B. Elyakov Pacific Institute of Bioorganic Chemistry of the Far Eastern Branch of the Russian Academy of Sciences
49 publications,
233 citations
h-index: 7
1 profile journal article
PhD in Chemistry
![G. B. Elyakov Pacific Institute of Bioorganic Chemistry of the Far Eastern Branch of the Russian Academy of Sciences](/storage/images/resized/NSnBPBb9hWBKaJIoIFXw3GdYcHGnwoHtnkdAYlir_small_thumb.webp)
G. B. Elyakov Pacific Institute of Bioorganic Chemistry of the Far Eastern Branch of the Russian Academy of Sciences
16 publications,
88 citations
h-index: 5
1 profile journal article
COURTINE Mélanie
🤝![Sorbonne Paris Nord University](/storage/images/resized/gr0MsNkja8ZMSh3RpGBrlc8q0i4XkiG9iZ4lyemr_small_thumb.webp)
Sorbonne Paris Nord University
10 publications,
153 citations
h-index: 4
Research interests
Big Data
Databases
Deep learning
Education
Image Analysis
Machine Learning
Medicine
1 profile journal article
Wiley Steven
129 publications,
7 405 citations
h-index: 46
1 profile journal article
Padez Cristina
137 publications,
15 794 citations
h-index: 31